Invivyd Net Worth
Invivyd Net Worth Breakdown | IVVD |
Invivyd Net Worth Analysis
Invivyd's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Invivyd's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Invivyd's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Invivyd's net worth analysis. One common approach is to calculate Invivyd's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Invivyd's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Invivyd's net worth. This approach calculates the present value of Invivyd's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Invivyd's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Invivyd's net worth. This involves comparing Invivyd's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Invivyd's net worth relative to its peers.
Enterprise Value |
|
To determine if Invivyd is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Invivyd's net worth research are outlined below:
| Invivyd generated a negative expected return over the last 90 days | |
| Invivyd has high historical volatility and very poor performance | |
| Invivyd has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (198.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Invivyd currently holds about 418.67 M in cash with (173.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Invivyd has a frail financial position based on the latest SEC disclosures | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: D. Boral Capital Reaffirms Buy Rating for Invivyd |
Invivyd uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Invivyd. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Invivyd's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Invivyd's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Invivyd is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Invivyd backward and forwards among themselves. Invivyd's institutional investor refers to the entity that pools money to purchase Invivyd's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.6 M | Millennium Management Llc | 2024-06-30 | 1.1 M | State Street Corp | 2024-06-30 | 982.7 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 786.9 K | Deutsche Bank Ag | 2024-06-30 | 646.9 K | Citadel Advisors Llc | 2024-09-30 | 625 K | Duquesne Family Office Llc | 2024-09-30 | 571.4 K | Northern Trust Corp | 2024-09-30 | 568.4 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 547.3 K | Maverick Capital Ltd | 2024-09-30 | 11.8 M | Deep Track Capital, Lp | 2024-09-30 | 11 M |
Follow Invivyd's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 80.65 M.Market Cap |
|
Project Invivyd's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.87) | (0.91) | |
| Return On Capital Employed | (1.16) | (1.22) | |
| Return On Assets | (0.87) | (0.91) | |
| Return On Equity | (1.12) | (1.06) |
When accessing Invivyd's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Invivyd's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Invivyd's profitability and make more informed investment decisions.
Please note, the presentation of Invivyd's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Invivyd's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Invivyd's management manipulating its earnings.
Evaluate Invivyd's management efficiency
Invivyd has return on total asset (ROA) of (0.5356) % which means that it has lost $0.5356 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9656) %, meaning that it created substantial loss on money invested by shareholders. Invivyd's management efficiency ratios could be used to measure how well Invivyd manages its routine affairs as well as how well it operates its assets and liabilities. As of November 30, 2024, Return On Tangible Assets is expected to decline to -0.91. In addition to that, Return On Capital Employed is expected to decline to -1.22. At present, Invivyd's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.01, whereas Non Current Assets Total are forecasted to decline to about 3.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.62 | 1.87 | |
| Tangible Book Value Per Share | 1.62 | 1.87 | |
| Enterprise Value Over EBITDA | (1.19) | (1.24) | |
| Price Book Value Ratio | 2.43 | 2.55 | |
| Enterprise Value Multiple | (1.19) | (1.24) | |
| Price Fair Value | 2.43 | 2.55 | |
| Enterprise Value | 233.1 M | 221.4 M |
The leadership approach at Invivyd's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Enterprise Value Revenue 3.0393 | Revenue 2.3 M | Revenue Per Share 0.02 | Return On Equity (0.97) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Invivyd insiders, such as employees or executives, is commonly permitted as long as it does not rely on Invivyd's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Invivyd insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Green Julie over three months ago Acquisition by Green Julie of 240000 shares of Invivyd at 4.43 subject to Rule 16b-3 | ||
Lee Timothy Edward over three months ago Insider Trading | ||
Mcguire Terrance over six months ago Acquisition by Mcguire Terrance of 50000 shares of Invivyd at 2.21 subject to Rule 16b-3 | ||
Gupta Srishti over six months ago Insider Trading | ||
Lindenboom Christine over six months ago Acquisition by Lindenboom Christine of 150000 shares of Invivyd subject to Rule 16b-3 | ||
Price Stacy over six months ago Acquisition by Price Stacy of 400000 shares of Invivyd subject to Rule 16b-3 | ||
Mcguire Terrance over a year ago Acquisition by Mcguire Terrance of 50000 shares of Invivyd subject to Rule 16b-3 |
Invivyd Earnings per Share Projection vs Actual
Invivyd Corporate Management
| Laura Walker | CoFounder Officer | Profile | |
| Elham PharmD | Chief Officer | Profile | |
| Peter MD | Chief Officer | Profile | |
| Robert Allen | Chief Officer | Profile | |
| Jill JD | Chief Secretary | Profile | |
| Mark Wingertzahn | Senior Affairs | Profile | |
| Timothy Lee | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invivyd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Invivyd Stock refer to our How to Trade Invivyd Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Invivyd. If investors know Invivyd will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Invivyd listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.95) | Revenue Per Share 0.02 | Return On Assets (0.54) | Return On Equity (0.97) |
The market value of Invivyd is measured differently than its book value, which is the value of Invivyd that is recorded on the company's balance sheet. Investors also form their own opinion of Invivyd's value that differs from its market value or its book value, called intrinsic value, which is Invivyd's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invivyd's market value can be influenced by many factors that don't directly affect Invivyd's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invivyd's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invivyd is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invivyd's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.